2026, Number 1
<< Back Next >>
Rev Mex Cir Bucal Maxilofac 2026; 22 (1)
Knowledge, attitudes and practices of dentistry students regarding the management of patients under antithrombotic therapy
Prado BNY, Cruz FA, Chaves CIA, Salgado CF
Language: Spanish
References: 26
Page: 4-11
PDF size: 446.19 Kb.
ABSTRACT
Introduction: the dental management of patients receiving antithrombotic therapy remains a clinical challenge due to the potential bleeding risk and the frequent misconception that medication must be discontinued before dental extraction. Current evidence indicates that most procedures can be safely performed without interrupting therapy when appropriate local hemostatic measures are implemented.
Objective: to evaluate the knowledge, attitudes, and practices of dentists regarding the management of patients under antithrombotic therapy, particularly concerning drug discontinuation prior to tooth extraction.
Material and methods: a cross-sectional observational study was conducted through a structured questionnaire distributed among dentists from various healthcare institutions. The survey assessed the identification of anticoagulant and antiplatelet agents, evaluation of bleeding risk, decisions regarding therapy suspension, and management of postoperative complications. Descriptive statistics were used for frequency and percentage analysis.
Results: although most respondents identified the main antithrombotic drugs, uncertainty persisted regarding therapy discontinuation. Sixty-two percent considered it necessary to suspend the medication before extraction, and only 28% were aware of clinical guidelines discouraging this practice. Forty percent reported feeling insecure when treating these patients, and over 70% had not received specific training on the subject.
Conclusions: sufficient knowledge was identified among dentists but inconsistent regarding the management of patients under antithrombotic therapy. Lack of awareness of current recommendations may increase thromboembolic and some trans or postoperative hemorrhagic risks, underscoring the need to strengthen professional education in pharmacology and clinical management.
REFERENCES
Schafer A, Flierl U, Berliner D, Bauersachs J. Anticoagulants for stroke prevention in atrial fibrillation in elderly patients. Cardiovasc Drugs Ther. 2020; 34 (4): 555-568. doi: 10.1007/s10557-020-06981-3.
Chen A, Stecker E, Warden BA. Direct oral anticoagulant use: a practical guide to common clinical challenges. J Am Heart Assoc. 2020; 9 (13): e017559. doi: 10.1161/JAHA.120.017559.
Teoh L, Moisés G, McCullough MJ. A review of drugs contributing to bleeding risk in general dental practice. Aust Dent J. 2020; 65 (2): 118-130.
Nazar JC, Cárdenas CA, Coloma DR, Contreras CJ, Molina I, Miranda HP et al. Manejo perioperatorio de pacientes con tratamiento anticoagulante crónico. Rev Chil Cir. 2018; 70 (1): 84-91.
Cebollada-del Misterio JM, Pérez-Contreras ME, Rodríguez-Álvarez M, Noguera-Franco M, Vilavella-Lizana C. Manejo de antiagregantes y anticoagulantes en el perioperatorio. FMC Form Med Contin Aten Prim. 2019; 26 (2): 104-115. doi: 10.1016/j.fmc.2018.09.002.
Johnson-Leong C. An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery. Int J Oral Maxillofac Surg. 2016; 45 (5): 618-630.
O'Connell JE, Stassen LFA. New oral anticoagulants and their implications for dental patients. J Ir Dent Assoc. 2014; 60 (3): 137-143.
Van Diermen DE, Van der Waal I, Hoogvliets MW, Ong FN, Hoogstraten J. Survey response of oral and maxillofacial surgeons on invasive procedures in patients using antithrombotic medication. Int J Oral Maxillofac Surg. 2013; 42 (4): 502-507. doi: 10.1016/j.ijom.2012.09.018.
Bensi C, Belli S, Paradiso D, Lomurno G. Postoperative bleeding risk of direct oral anticoagulants after oral surgery procedures: a systematic review and meta-analysis. Int J Oral Maxillofac Surg. 2018; 47 (7): 923-932.
Broekema FI, Van Minnen B, Jansma J, Bos RRM. Risk of bleeding after dentoalveolar surgery in patients taking anticoagulants. Br J Oral Maxillofac Surg. 2014; 52 (3): e15-e19.
Melgaard L, Gorst-Rasmussen A, Lane DA, Rasmussen LH, Larsen TB, Lip GYH. Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation. JAMA. 2015; 314 (10): 1030-1038. doi: 10.1001/jama.2015.10725.
Serrano-Sánchez V, Ripollés-de Ramón J, Collado-Yurrita L, Vaello-Checa I, Colmenero-Ruiz C, Helm A et al. New horizons in anticoagulation: direct oral anticoagulants and their implications in oral surgery. Med Oral Patol Oral Cir Bucal. 2017; 22 (5): e601-e608. doi: 10.4317/medoral.21862.
Martínez-Moreno E, Martínez-López F, Rodríguez-Lozano FJ, Oñate-Sánchez RE. Bleeding complications in anticoagulated and/or antiplatelet-treated patients at the dental office: a retrospective study. Int J Environ Res Public Health. 2021; 18 (4): 1609. doi: 10.3390/ijerph18041609.
Zhu W, He W, Guo L, Wang X, Hong K. The HAS-BLED score for predicting major bleeding risk in anticoagulated patients with atrial fibrillation: a systematic review and meta-analysis. Clin Cardiol. 2015; 38 (9): 555-561. doi: 10.1002/clc.22435.
Obamiro KO, Chalmers L, Bereznicki LR. Development and validation of an oral anticoagulation knowledge tool (AKT). PLoS One. 2016; 11 (6): e0158071. doi: 10.1371/journal.pone.0158071.
Ramírez-Prieto G, Pombo-Bartelt JE, Rojas-Calderón G, García-González JJ. Prescripción de anticoagulación oral en el paciente geriátrico con fibrilación auricular. Arch Cardiol Mex. 2022; 92 (1): 42-52.
Torres-Martínez JM. Estilos de vida de los pacientes anticoagulados vista desde el modelo de creencias de salud. Rev Mex Enferm Cardiol. 2022; 30 (2): 47-54.
Srivastava KC, Shrivastava D, Baig MN, Sghaireen MG, Kielbassa AM, Lynch E. Knowledge, attitude, and practice of institutional dental professionals regarding management of patients taking oral antithrombotic medications. Acad J. 2020; 51 (8): 650.
Sánchez-Fúnez S. Conocimientos de los alumnos de odontología sobre fármacos antiagregantes y anticoagulantes [tesis de licenciatura]. Barcelona: Universitat de Barcelona, Facultat de Medicina i Ciéncies de la Salut; 2023.
van Diermen DE, Bruers JJ, Hoogstraten J, Bovenlander M, van den Bosch A, van der Waal I. Treating dental patients who use oral antithrombotic medication: a survey of dentists in the Netherlands. J Am Dent Assoc. 2011; 142 (12): 1376-1382.
Bayón J, Gordo V, Santás-Álvarez M, Lozano I, Ríos-Vázquez R, González-Juanatey C. Grado de conocimiento de los anticoagulantes orales y la fibrilación auricular entre los odontólogos de España. REC: CardioClinics. 2019; 54 (2): 133-135.
Shah AH, Khalil HS, Alshahrani FA, Khan SQ, AlQthani NR, Bukhari IA et al. Knowledge of medical and dental practitioners towards dental management of patients on anticoagulant and/or antiplatelet therapy. Saudi J Dent Res. 2015; 6 (2): 91-97. doi: 10.1016/j.sjdr.2014.10.002.
Palareti G, Antonucci E, Mastroiacovo D, Ageno W, Pengo V, Poli D et al. The American College of Chest Physicians score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism. J Thromb Haemost. 2018; 16 (10): 1994-2002.
Moldovan MA, Filip LV, Ciurea M, Termure DA, Ostas D, Rotar H et al. Bleeding and thromboembolic risk in patients under anticoagulant therapy receiving oral surgery: a systematic review. Med Pharm Rep. 2023; 96 (4): 346-357. doi: 10.15386/mpr-2519.
Barnes GD, Mouland E. Peri-procedural management of oral anticoagulants in the DOAC era. Prog Cardiovasc Dis. 2018; 60 (6): 600-606. doi: 10.1016/j.pcad.2018.03.002.
Sahar-Helft S, Chackartchi T, Polak D, Findler M. Dental treatment in the era of new anti-thrombotic agents. Int Dent J. 2018; 68 (3): 131-137.